Mingbin Zheng
- Biomedical Engineering top 0.2%
- Biomaterials top 0.2%
- Molecular Biology top 5%
- Materials Chemistry top 2%
- Pulmonary and Respiratory Medicine top 2%
- Topics
- Nanoplatforms for cancer theranostics (40 papers)Nanoparticle-Based Drug Delivery (24 papers)RNA Interference and Gene Delivery (9 papers)
- Partner nations
- ChinaIranUnited States
In The Last Decade
Mingbin Zheng
74 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Biomedical Engineering 5.4k
- Biomaterials 2.2k
- Molecular Biology 1.9k
- Materials Chemistry 1.8k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Mingbin Zheng
This map shows the geographic impact of Mingbin Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingbin Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingbin Zheng more than expected).
Fields of papers citing papers by Mingbin Zheng
This network shows the impact of papers produced by Mingbin Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingbin Zheng. The network helps show where Mingbin Zheng may publish in the future.
Co-authorship network of co-authors of Mingbin Zheng
This figure shows the co-authorship network connecting the top 25 collaborators of Mingbin Zheng. A scholar is included among the top collaborators of Mingbin Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingbin Zheng. Mingbin Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 3 | |
| 5 | 7 | |
| 6 | 24 | |
| 7 | 10 | |
| 8 | 60 | |
| 9 | 31 | |
| 10 | 0 | |
| 11 | 91 | |
| 12 | 46 | |
| 13 | 10 | |
| 14 | 10 | |
| 15 | 87 | |
| 16 | 184 | |
| 17 | 336 | |
| 18 | 12 | |
| 19 | 241 | |
| 20 | 30 |
About Mingbin Zheng
Mingbin Zheng is a scholar working on Biomaterials, Biomedical Engineering and Biotechnology, having authored 77 papers that have together received 6.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (40 papers), Nanoparticle-Based Drug Delivery (24 papers) and RNA Interference and Gene Delivery (9 papers). The work is most often cited by research in Biomaterials (2.2k citations), Biomedical Engineering (5.4k citations) and Biotechnology (463 citations). Mingbin Zheng has collaborated with scholars based in China, Iran and United States. Frequent co-authors include Lintao Cai, Yifan Ma, Pengfei Zhao, Zonghai Sheng, Ping Gong, Zhenyu Luo, Pengfei Zhang, Ai-Qing Ma, Lanlan Liu and Cuifang Zheng. Their work appears in journals such as Advanced Materials, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.